Suchergebnisse - "Mease, Philip J"

PubPharm (706)

1

Machine learning to understand risks for severe COVID-19 outcomes : a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system

enthalten in: The Lancet. Digital health | 2024

von Wei, Q. | Mease, P. | Chiorean, M. | +8

2

Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains : results from two phase 3 randomised studies, BE MOBILE 1 and 2

enthalten in: RMD open | 2024

von Navarro-Compán, V. | Ramiro, S. | Deodhar, A. | +9

3

Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer

enthalten in: Cell reports | 2024

von Chen, D. | Xie, J. | Choi, J. | +15

4

Improvements in patient-reported outcomes after treatment with deucravacitinib in patients with psoriatic arthritis : results from a randomized phase 2 trial

enthalten in: Arthritis care & research | 2024

von Strand, V. | Gossec, L. | Coates, L. | +9

5

Guselkumab provides durable improvement across psoriatic arthritis disease domains : post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study

enthalten in: RMD open | 2024

von Coates, L. | Gossec, L. | Zimmermann, M. | +8

6

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2023 update

enthalten in: Annals of the rheumatic diseases | 2024

von Gossec, L. | Kerschbaumer, A. | Ferreira, R. | +33

7

Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison

enthalten in: Rheumatology and therapy | 2024

von Warren, R. | McInnes, I. | Nash, P. | +6

8

Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis

enthalten in: Rheumatology and therapy | 2024

von Curtis, J. | McInnes, I. | Rahman, P. | +10

9

Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison

enthalten in: Rheumatology and therapy | 2024

von Mease, P. | Warren, R. | Nash, P. | +6

10

Patient clusters identified by machine learning from a pooled analysis of the clinical development programme of secukinumab in psoriatic arthritis, ankylosing spondylitis and psoriatic arthritis with axial manifestations

enthalten in: Clinical and experimental rheumatology | 2024

von Baraliakos, X. | Pournara, E. | Coates, L. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[71]